Capricor Therapeutics (CAPR) Change in Account Payables (2010 - 2023)
Capricor Therapeutics' (CAPR) quarterly Change in Account Payables came in at $7302.0 in Q4 2023, up 43.8% year-on-year from $5078.0 in Q4 2022, and up 371.1% quarter-over-quarter from $1550.0 in Q3 2023.
Capricor Therapeutics (CAPR) Change in Account Payables (2010 - 2023) Analysis & Trends
Capricor Therapeutics' Change in Account Payables history runs 8 years deep, the most recent figure standing at $7302.0 for Q4 2023.
- On a quarterly basis, Change in Account Payables rose 43.8% year-over-year to $7302.0 in Q4 2023; TTM through Dec 2023 was -$61755.0, a 87.89% increase from a year earlier, with the FY2023 full-year figure at -$61755.0, up 87.89% from the prior year.
- Change in Account Payables grew to $7302.0 in Q4 2023 per CAPR's latest filing, from $1550.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $312362.0 in Q1 2021 and bottomed at -$480713.0 in Q2 2022.
- The 3-year median for Change in Account Payables is $3314.0 (2022), against an average of $1542.2.
- Across the five-year window, Change in Account Payables slumped 985.01% in 2022 and jumped 115.53% in 2023, its largest moves.
- Year by year, Change in Account Payables stood at $102308.0 in 2021, then sank by 95.04% to $5078.0 in 2022, then jumped by 43.8% to $7302.0 in 2023.
- Per Business Quant, the three latest CAPR Change in Account Payables figures stand at $7302.0 (Q4 2023), $1550.0 (Q3 2023), and -$89.0 (Q2 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 7,302.00 |
| Dec 31, 2023 | 7,302.00 |
| Sep 30, 2023 | 1,550.00 |
| Sep 30, 2023 | 1,550.00 |
| Jun 30, 2023 | -89.00 |
| Jun 30, 2023 | -89.00 |
| Mar 31, 2023 | -70,518.00 |
| Mar 31, 2023 | -70,518.00 |
| Dec 31, 2022 | 5,078.00 |
| Dec 31, 2022 | 5,078.00 |
| Sep 30, 2022 | -9,979.00 |
| Sep 30, 2022 | -9,979.00 |
| Jun 30, 2022 | -480,713.00 |
| Jun 30, 2022 | -480,713.00 |
| Mar 31, 2022 | -24,540.00 |
| Mar 31, 2022 | -24,540.00 |
| Dec 31, 2021 | 102,308.00 |
| Dec 31, 2021 | 102,308.00 |
| Sep 30, 2021 | 121,429.00 |
| Sep 30, 2021 | 121,429.00 |